This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Karnofsky, D. A. Search for Related Content PubMed PubMed Citation Articles by Karnofsky, D. A.

The Staging of Hodgkin's Disease¹

Division of Clinical Chemotherapy, The Sloan-Kettering Institute for Cancer Research, New York, New York

The interpretation of the clinical status of Hodgkin's disease is based on the histology of the involved node, the patient's age and sex, the anatomic extent of the disease, and the presence or absence of systemic symptoms. The necessary survey of the patient at the time of diagnosis includes symptomatic history, complete physical examination, laboratory studies, and X-ray examinations including lymphangiography. The usual stagings of Hodgkin's disease are: Stage I, localized disease; Stage II, regional disease above or below the diaphragm; Stage III, disease both above and below the diaphragm; and Stage IV, extranodal disease. Subtype A refers to the absence, and B to the presence, of symptoms.

Accurate staging is of importance in suggesting prognosis, determining the most effective forms of treatment, and in providing a basis for comparison of the clinical experiences of different clinics.

¹ This program is supported in part by Research Grants CA-03215 and CA-05826 from the National Cancer Institute, USPHS, Bethesda, Maryland.